Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorThomas Jefferson University

About this trial

This clinical trial evaluates whether having a trained peer navigator helps African American men with prostate cancer that has spread to other parts of the body (metastatic) understand and navigate the genetic testing process better than not having a peer navigator. Genetic testing for men with prostate cancer is very important for making treatment and management decisions. However, understanding the risks, benefits, and steps of genetic counseling and testing can be very challenging for patients. African American men are especially less likely to participant in genetic testing due to lack of awareness or understanding, cultural beliefs, finances, or mistrust of the healthcare system. A peer navigator, someone who helps a patient through the information and the process, may be helpful to some men. This study evaluates whether having a peer navigator throughout the genetic evaluation process helps patients understand and engage in the process more.

Eligibility criteria

Qualifiers

Provide signed and dated informed consent form

English speaking only

Willing to comply with all study procedures and be available for the duration of the study

Any individual >= 18 years old

Disqualifiers

Patients that do not meet the inclusion criteria and children under the age of 18 will be excluded

Anyone who has trouble understanding the consent or with significant anxiety detected during the consent process will also be excluded

Trial design

Treatments tested in this trial

  • Patient Navigation
  • Genetic Counseling
  • Survey Administration
  • Best Practice
  • Genetic Counseling
  • Survey Administration

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators